English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45346/58522 (77%)
造訪人次 : 2506090      線上人數 : 230
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/51508


    題名: 自噬現象及其調控在脊髓損傷治療的應用研究
    Autophagy and its manipulation for possible application in treatment of spinal cord injury
    作者: 陳先志
    Chen, Hsien-Chih
    關鍵詞: 脊髓損傷;自噬;雷帕黴素;穿透式電子顯微鏡;微管相關蛋白輕鏈;3 spinal cord injury;autophagy;rapamycin;transmission electron microscopy;microtubule-associated protein 3
    日期: 2012-06-16
    上傳時間: 2018-10-12 16:01:03 (UTC+8)
    摘要: 脊髓損傷是一種對病患生理及心理具有嚴重破壞性影響的傷病,除了病患個人,對於其家庭和社會成本而言,實際上付出的代價也是非常巨大。雖然我們在了解脊髓損傷的病理生理機轉上已有顯著的進展,然而有關其引起後續細胞死亡的機制仍然不完全理解。細胞的死亡有三個主要類型,包括細胞壞死,細胞凋亡和細胞自噬。細胞壞死和細胞凋亡已知會在脊髓損傷以後發生,但細胞自噬這種細胞死亡方式則尚不清楚是否會發生。原發的衝擊損傷導致的細胞壞死是無法預防的,但在損傷震央附近的細胞雖倖免於最初的重創,卻可能會面臨繼發的生物化學影響所啟動的凋亡和自噬作用而導致細胞死亡。因此,本論文的主要目的,在於探討自噬現象在脊髓損傷後的發生與否,並期望藉由調控自噬現象來發展新的脊髓損傷治療對策。

    在我們前段的研究,我們藉由西方墨點免疫印跡,免疫螢光和透射電子顯微鏡來證明自噬現象存在於大鼠脊髓損傷模型中。我們還發現了細胞自噬表現在實驗性大鼠脊髓損傷的時間過程,以及在急性期特定細胞的表現及其與細胞凋亡的關聯。鑒於一些研究已經提到了細胞自噬在神經退化性疾病和腦缺氧缺血引起的腦損傷中可能的保護作用,我們在後續的研究,假設在脊髓損傷後神經細胞的死亡,是可以經由調控細胞自噬的表現而加以避免。我們藉由西方墨點免疫印跡及大鼠運動功能評估,發現自噬現象是可以透過雷帕黴素抑制mTOR而使其表現增強,而且可以顯著地改善脊髓損傷大鼠運動功能的恢復;因此我們更深入探討雷帕黴素對大鼠脊髓損傷的影響,發現除了增進自噬表現以外,它在脊髓損傷模型中也有抗發炎反應及減少神經細胞損害的功能,因此而達到增進大鼠運動功能恢復的成果。

    本研究藉由大鼠脊髓損傷模型印證自噬現象的存在,及其受調控後在脊髓損傷治療應用上的可能性,未來除了更深入探討細胞自噬與細胞凋亡的關聯,也可進一步發展藥物在外科手術治療後局部或靜脈給予,並參與有潛力的雞尾酒療法,以加速脊髓損傷臨床治療的進步。

    Spinal cord injury (SCI) is a serious and debilitating health problem. Quite apart from the emotional and physical stress of SCI to the patient, the actual monetary costs of SCI to the family and community are enormous. Although remarkable progress has been made in pathophysiological mechanisms of SCI, the mechanisms causing cell deaths after SCI are still incompletely understood. There are three main types of cell death, including necrosis, autophagy and apoptosis. Cell deaths due to necrosis and apoptosis are known to occur after SCI; however, autophagic cell death is unclear. Prevention of cell necrosis before the primary injury is not possible. Cells around the epicenter of injuries that are spared from the initial trauma may experience a secondary biochemical insult to initiate the apoptosis and autophagic cell deaths. Therefore, the main purpose of this paper, is to explore the phenomenon of autophagy in spinal cord after injury or not, and hope that through manipulation of autophagy we can develop novel treatment for SCI.

    In our first research, we depended on Western blotting, immunofluorescence, and transmission electron microscopy to prove autophagy expression exists in rat spinal cord injury model. We also found the time course of autophagy expression in experimental rat SCI, as well as autophagy expression in specific cells in the early stages and its correlation with apoptosis. As some researches in neurodegenerative diseases and brain hypoxia-ischemia, autophagy may induce neuroprotective effects on brain damage. We assumed death of neurons after SCI is possible avoided via manipulation of autophagy expression in the following study. We found rapamycin could increase autophagy expression by inhibition of mTOR through Western blots, and it was able to improve locomotor recovery in rats after SCI by way of BBB locomotor evaluation. We then in-depth explored the effects of rapamycin on SCI in rats. We found apart from promotion of autophagy, rapamycin has effects of anti-inflammation and reduction of neuronal damage, which leads to improvement of functional recovery.

    Through this study in rats with SCI model proves existence of autophagy, and possibility for therapeutic application by manipulation of autophagy in SCI. In the future, we can further develop local or intravenous administration of drugs after surgical treatment, and participate in the potential cocktail therapy, to speed up the advancement of clinical therapy for spinal cord injury.
    描述: 博士
    委員-陳志華
    委員-陳瑞明
    委員-陳子勇
    委員-馮琮涵
    指導教授-邱文達
    資料類型: thesis
    顯示於類別:[臨床醫學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML105檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋